- Home
- NEN vs BWAY Comparison
NEN vs BWAY Comparison
Compare NEN & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEN
- BWAY
- Stock Information
- Founded
- NEN 1977
- BWAY 2003
- Country
- NEN United States
- BWAY Israel
- Employees
- NEN N/A
- BWAY N/A
- Industry
- NEN Building operators
- BWAY Medical/Dental Instruments
- Sector
- NEN Real Estate
- BWAY Health Care
- Exchange
- NEN Nasdaq
- BWAY Nasdaq
- Market Cap
- NEN 262.4M
- BWAY 220.7M
- IPO Year
- NEN N/A
- BWAY 2019
- Fundamental
- Price
- NEN $72.49
- BWAY $11.47
- Analyst Decision
- NEN
- BWAY Strong Buy
- Analyst Count
- NEN 0
- BWAY 2
- Target Price
- NEN N/A
- BWAY $14.25
- AVG Volume (30 Days)
- NEN 450.0
- BWAY 47.5K
- Earning Date
- NEN 01-01-0001
- BWAY 08-13-2025
- Dividend Yield
- NEN 6.62%
- BWAY N/A
- EPS Growth
- NEN 58.97
- BWAY N/A
- EPS
- NEN 4.56
- BWAY 0.08
- Revenue
- NEN $82,531,485.00
- BWAY $43,457,000.00
- Revenue This Year
- NEN N/A
- BWAY $341.83
- Revenue Next Year
- NEN N/A
- BWAY $23.42
- P/E Ratio
- NEN $15.89
- BWAY $56.90
- Revenue Growth
- NEN 6.12
- BWAY 26.86
- 52 Week Low
- NEN $68.98
- BWAY $5.98
- 52 Week High
- NEN $84.00
- BWAY $13.66
- Technical
- Relative Strength Index (RSI)
- NEN 37.80
- BWAY 41.46
- Support Level
- NEN $72.26
- BWAY $11.54
- Resistance Level
- NEN $73.44
- BWAY $12.08
- Average True Range (ATR)
- NEN 0.16
- BWAY 0.50
- MACD
- NEN -0.01
- BWAY -0.12
- Stochastic Oscillator
- NEN 13.22
- BWAY 7.20
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.